Particle.news

Download on the App Store

Supreme Court Questions Basis of Lawsuit Against Abortion Drug Mifepristone

The justices express skepticism over anti-abortion doctors' standing in a case that could impact access to medication abortions.

  • Supreme Court appears skeptical of anti-abortion doctors' claims against FDA's approval of mifepristone, questioning their legal standing.
  • Mifepristone, a key drug in medication abortions, remains under scrutiny as courts evaluate its FDA approval and subsequent deregulation.
  • Critics argue the lawsuit against mifepristone lacks scientific basis, citing discredited studies and anonymous blog posts.
  • The case has sparked broader discussions about the Comstock Act and potential new avenues for restricting access to abortion.
  • Public and political reactions to the case are divided, with rallies and legislative proposals reflecting deep-seated opinions on abortion.
Hero image